Indicators of Prognosis in Node-Negative Breast Cancer

Helgi Sigurðsson, Bo Baldetorp, Åke Borg, +4

New England Journal of Medicine

Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular dna content

Pelle Gustafson, Anders Rydholm, Helena Willén, +3

Cancer

ERBB2 amplification in breast cancer with a high rate of proliferation.

Åke Borg, Bo Baldetorp, Mårten Fernö, +2

PubMed

Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.

Karin Rennstam, Minna Ahlstedt-Soini, Bo Baldetorp, +6

PubMed

Breast OncologyGroup ACancer PathologyGeneticsComparative Genomic Hybridization +14

Chromosome aberrations in 35 primary ovarian carcinomas

Tanja Pejović, Sverre Heim, Felix Mitelman, +8

Genes Chromosomes and Cancer

Karyotype ImagingStructural AberrationsClonal Chromosome AberrationsTumoral PathologyCancer Pathology +12

Correlation between p53, c-erbB-2, and topoisomerase II? expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications

Pierre Rudolph, Håkan Olsson, G. Bonatz, +6

The Journal of Pathology

Breast OncologyNode-negative Breast CarcinomasMedicineImmunologyPathology +11

c‐<i>myc</i> amplification is an independent prognostic factor in postmenopausal breast cancer

Åke Borg, Bo Baldetorp, Mårten Fernö, +2

International Journal of Cancer

Heterogenous mismatch-repair status in colorectal cancer

Patrick Joost, Nynke Veurink, Susanne Holck, +6

Diagnostic Pathology

Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma

Katja Harbst, Martin Lauss, Helena Cirenajwis, +12

Cancer Research

Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience.

Thor Alvegård, Nils O. Berg, Bo Baldetorp, +5

Journal of Clinical Oncology

Tumor BiologyTumoral Pathology5-Year MfsNuclear Dna ContentMedicine +12